NCT02320526

Brief Summary

Interval training is superior to continuous training for improving glycemic control, hereunder glycemic variability and -spikes. However, the underlying mechanisms and the clinical impact is at present unknown. The overall objective of this project is to determine the mechanisms underlying aeroic interval-training-induced reductions in glycemic variability and -spikes, and the impact on levels of systemic inflammation in type 2 diabetes patients. It is hypothesized that aerobic interval training reduces glycemic variability and -spikes more than continuous training due to larger improvements in both peripheral insulin sensitivity and the mass action effect of glucose. Moreover, it is hypothesized that these reductions in glycemic variability and -spikes also reduces systemic inflammation.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
14

participants targeted

Target at below P25 for not_applicable diabetes-mellitus-type-2

Timeline
Completed

Started Nov 2014

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2014

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

December 8, 2014

Completed
11 days until next milestone

First Posted

Study publicly available on registry

December 19, 2014

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2016

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2016

Completed
Last Updated

April 27, 2016

Status Verified

April 1, 2016

Enrollment Period

1.3 years

First QC Date

December 8, 2014

Last Update Submit

April 26, 2016

Conditions

Keywords

ExerciseTrainingInterval trainingSystemic inflammationGlucose disposalInsulin sensitivityGlucose effectiveness

Outcome Measures

Primary Outcomes (1)

  • Glycemic control

    Glycemic control incl. glycemic variability and -spikes, will be measured with continuous glucose monitoring over 24 hours during standardized dietary intake before and after each intervention.

    Change from baseline at 14 days

Secondary Outcomes (2)

  • Urinary isoprostanes as a measure of systemic inflammation

    Change from baseline at 14 days

  • Rate of dissappearance during a 2-step (pancreatic + hyperinsulinemic) hyperglycemic clamp, as a measure of glucose effectiveness + insulin sensitivity

    Change from baseline at 14 days

Other Outcomes (1)

  • Resting energy expenditure and respiratory exchange rate

    Change from baseline at 14 days

Study Arms (3)

Control

EXPERIMENTAL

Control intervention: Subjects will continue their life unaltered during the 14 days intervention period

Behavioral: Control

Continuous walking

EXPERIMENTAL

Training intervention: Subjects will perform continuous walking for one hour per day at every weekday during the 14 days intervention period

Behavioral: Continuous walking

Interval Walking

EXPERIMENTAL

Training intervention: Subjects will perform interval walking for one hour per day at every weekday during the 14 days intervention period. Interval walking will be performed as repeated cycles of three minutes of slow and hree minutes of fast walking during the entire training session

Behavioral: Interval walking

Interventions

ControlBEHAVIORAL
Also known as: CON
Control
Also known as: CWT
Continuous walking
Also known as: IWT
Interval Walking

Eligibility Criteria

Age40 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Type 2 diabetes mellitus
  • BMI \>18 but \<40 kg/m2

You may not qualify if:

  • Pregnancy
  • Smoking
  • Contraindication to increased levels of physical activity
  • More than moderate levels of physical activity (\>90 min/week) of maximally moderate intensity
  • Insulin dependence
  • Thyroid, liver, lung, heart or kidney disease, with the need for treatment

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The Centre for Physical Activity Research, Rigshospitalet

Copenhagen, 2100, Denmark

Location

Related Publications (3)

  • Karstoft K, Clark MA, Jakobsen I, Knudsen SH, van Hall G, Pedersen BK, Solomon TPJ. Glucose effectiveness, but not insulin sensitivity, is improved after short-term interval training in individuals with type 2 diabetes mellitus: a controlled, randomised, crossover trial. Diabetologia. 2017 Dec;60(12):2432-2442. doi: 10.1007/s00125-017-4406-0. Epub 2017 Aug 25.

  • Karstoft K, Brinklov CF, Thorsen IK, Nielsen JS, Ried-Larsen M. Resting Metabolic Rate Does Not Change in Response to Different Types of Training in Subjects with Type 2 Diabetes. Front Endocrinol (Lausanne). 2017 Jun 13;8:132. doi: 10.3389/fendo.2017.00132. eCollection 2017.

  • Karstoft K, Clark MA, Jakobsen I, Muller IA, Pedersen BK, Solomon TP, Ried-Larsen M. The effects of 2 weeks of interval vs continuous walking training on glycaemic control and whole-body oxidative stress in individuals with type 2 diabetes: a controlled, randomised, crossover trial. Diabetologia. 2017 Mar;60(3):508-517. doi: 10.1007/s00125-016-4170-6. Epub 2016 Dec 9.

MeSH Terms

Conditions

Diabetes Mellitus, Type 2Motor ActivityInsulin Resistance

Condition Hierarchy (Ancestors)

Diabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesBehaviorHyperinsulinism

Study Officials

  • Kristian Karstoft, MD, PhD

    Rigshospitalet, The Centre for Physical Activity Research

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD, PhD

Study Record Dates

First Submitted

December 8, 2014

First Posted

December 19, 2014

Study Start

November 1, 2014

Primary Completion

February 1, 2016

Study Completion

April 1, 2016

Last Updated

April 27, 2016

Record last verified: 2016-04

Locations